Diagnosis and treatment of hepatocellular carcinoma

HepatologyGastroenterologyOncologyInfectious diseases
Written By August Felix

This activity is older than 12 months.

This case study has been developed with the assistance of Ghassan K. Abou-Alfa, MD (Associate Professor, Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA), Josep M. Llovet, MD, PhD (Professor of Research-ICREA in the BCLC Group, Liver Unit, IDIBAPS-Hospital Clinic of Barcelona, Spain) and Amit Singal, MD (Medical Director of the Liver Tumor Program, UT Southwestern Medical Center, Dallas, Texas, USA). Supported by an independent educational grant from Bayer Healthcare.

Modules

  • A 60-year-old Asian man with advanced hepatocellular carcinoma (HCC) and a history of HBV-induced cirrhosis

  • A 69-year-old white woman with advanced hepatocellular carcinoma (HCC) and a history of HCV-induced cirrhosis

  • A 66-year-old woman with progressive hepatocellular carcinoma (HCC) on sorafenib treatment

August Felix
Previous

Early treatment of congenital and acquired hemophilia
Next

Management of Severe Bleeding in Cardiac Surgery and Trauma Patients